177 Education and Its Effects on Barriers to Clinical Trial Participation in Alzheimer’s Disease Studies by Underrepresented Communities
OBJECTIVES/GOALS: Minoritized populations experience a large burden of Alzheimer’s Disease; interventions are often delayed and underrepresented communities’ participation in clinical trial research is low. Lack of information has been proposed as a barrier to clinical research enrollment of minorit...
Main Authors: | Mallory Ziegler, Alexandrea Adams, Jingtao Zhu, Allison Case, Natalie Argueta, Ashley Regling, Gregory Wilding, Kinga Szigeti |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-04-01
|
Series: | Journal of Clinical and Translational Science |
Online Access: | https://www.cambridge.org/core/product/identifier/S205986612300256X/type/journal_article |
Similar Items
-
Barriers and facilitators to recruitment of underrepresented research participants: Perspectives of clinical research coordinators
by: Marie E. Heffernan, et al.
Published: (2023-01-01) -
“There’s not much we can do…” researcher-level barriers to the inclusion of underrepresented participants in translational research
by: Susan Racine Passmore, et al.
Published: (2022-01-01) -
Factors and barriers that influence the matriculation of underrepresented students in medicine
by: Cynthia Tello, et al.
Published: (2023-05-01) -
CHRFAM7A: A human specific fusion gene, accounts for the translational gap for cholinergic strategies in Alzheimer's disease
by: Kinga Szigeti, et al.
Published: (2020-09-01) -
Factors influencing participation of underrepresented students in STEM fields: matched mentors and mindsets
by: Katherine Kricorian, et al.
Published: (2020-04-01)